Valuation: Healthconn Corp.

Market Cap 952M 29.65M 26M 24.01M 22.19M 42.05M 2.84B 42.89M 289M 112M 1.39B 111M 109M 4.82B P/E 2024
43.8x
P/E 2025 108x
Enterprise Value 833M 25.94M 22.75M 21M 19.41M 36.79M 2.48B 37.52M 252M 98.1M 1.22B 97.4M 95.26M 4.22B EV / Sales 2024
0.41x
EV / Sales 2025 0.7x
Free-Float
58.01%
Yield 2024
3.81%
Yield 2025 0.74%
1 day+5.00%
1 week+6.06%
Current month+6.06%
1 month+9.95%
3 months+6.06%
6 months+7.97%
Current year+4.74%
1 week 19.1
Extreme 19.1
21.2
1 month 18.5
Extreme 18.5
21.55
Current year 18.4
Extreme 18.4
24.4
1 year 18.4
Extreme 18.4
26.15
3 years 16.9
Extreme 16.9
38.75
5 years 16.9
Extreme 16.9
57.2
10 years 16.9
Extreme 16.9
247.02
Manager TitleAgeSince
Chief Executive Officer - 2023-12-20
Director of Finance/CFO - 2018-12-20
Comptroller/Controller/Auditor - 2021-03-21
Director TitleAgeSince
Director/Board Member - 2017-12-26
Director/Board Member - 2020-06-21
Director/Board Member - 2022-06-16
Change 5-day change 1-year change 3-year change Capi.($)
+5.00%+6.06%-15.49%-39.91% 28.22M
-1.70%+0.35%-34.13%-57.55% 179M
+9.98%+8.41%-25.92%+12.52% 51.8M
Average +4.43%+5.18%-25.18%-28.31% 86.33M
Weighted average by Cap. +1.37%+2.20%-30.46%-41.61%

Financials

2024 2025
Net sales 1.25B 39.02M 34.22M 31.59M 29.2M 55.34M 3.74B 56.45M 380M 148M 1.83B 147M 143M 6.35B 1.13B 35.21M 30.88M 28.51M 26.35M 49.94M 3.37B 50.94M 343M 133M 1.65B 132M 129M 5.73B
Net income 19.23M 599K 525K 485K 448K 849K 57.32M 866K 5.83M 2.26M 28.05M 2.25M 2.2M 97.37M 8.39M 261K 229K 212K 196K 371K 25.02M 378K 2.54M 988K 12.24M 981K 960K 42.51M
Net Debt -317M -9.88M -8.67M -8M -7.4M -14.02M -946M -14.3M -96.21M -37.38M -463M -37.11M -36.3M -1.61B -119M -3.71M -3.26M -3.01M -2.78M -5.26M -355M -5.37M -36.13M -14.04M -174M -13.94M -13.63M -604M
Logo Healthconn Corp.
HEALTHCONN CORP. is a Taiwan-based Company mainly engaged in the provision of disease prevention and treatment services. The Company is engaged in the provision of precisely prevent medical integration services, molecular biology testing programs and accurate diagnostic testing services. The precisely prevent medical integration services include precisely prevention, disease management and health promotion services. The molecular bioassay services include food safety testing and functional medical testing services. The accurate diagnostic testing services include molecular testing and clinical microbiological testing services, as well as the development and operation of medical health institutions. The Company is also engaged in the medical equipment sale business. The Company operates in the Taiwan market as well as in the mainland China market.
Employees
205
Date Price Change Volume
26-07-07 NT$21.00 +5.00% 56,145
26-07-07 NT$20.00 -3.85% 14,610
26-07-06 NT$20.80 +4.52% 28,229
26-07-03 NT$19.90 +1.53% 41,630
26-07-02 NT$19.60 -0.76% 11,526
  1. Stock Market
  2. Stocks
  3. 6665 Stock